Chemosensitivity of human malignant glioma: modulation by p53 gene transfer
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 39 (1) , 19-32
- https://doi.org/10.1023/a:1005910323338
Abstract
Loss of wild-type p53 activity is one of the most common molecular abnormalities in human cancers including malignant gliomas. The p53 status is also thought to modulate sensitivity to irradiation...Keywords
This publication has 55 references indexed in Scilit:
- CLINICAL IMPLICATIONS OF THE p53 GENEAnnual Review of Medicine, 1996
- Management of primary malignant brain tumours.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific MannerDNA and Cell Biology, 1995
- Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genesInternational Journal of Cancer, 1995
- A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient miceNature Genetics, 1995
- p53 Mutation, Expression, and DNA Ploidy in Evolving Gliomas: Evidence for Two Pathways of ProgressionJNCI Journal of the National Cancer Institute, 1994
- Transforming growth factor‐β2 induces apoptosis of murine T cell clones without down‐regulating bcl‐2 mRNA expressionEuropean Journal of Immunology, 1994
- Expression of the p53 Tumor Suppressor Gene Product Is a Determinant of ChemosensitivityBiochemical and Biophysical Research Communications, 1994
- The basis for current treatment recommendations for malignant gliomasJournal of Neuro-Oncology, 1994
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993